Flamicort 10mg/ml injection
Ingredients in every 5 ml
Each package contains
|ATC Level 1||H - Systemic hormonal preparations; excluding sex hormones and insulins|
|ATC Level 2||H02 - Corticosteroids for Systemic Use|
|ATC Level 3||H02A - Corticosteroids for Systemic Use; Plain|
INTRA-ARTICULAR OR INTRABURSAL
Initial dose: from 2.5 to 5 mg for smaller joints, 5 to 15 mg for larger joints. Single injections into several joints for multiple locus involvement, up to a total of 20 mg or more, have been given without incident.
Initial dose: limited to 1.0 mg (0.1 ml) per injection site.
Flamicort injection 10 mg/ml is indicated for intra-articular or intrabursal administration and for injection into tendon sheaths as adjunctive therapy for short term administration (to tide the patient over an acute episode exacerbation) in: synovitis of osteoarthritis, rheumatoid arthritis, acute or sub-acute bursitis, acute gouty arthritis, epicondylitis, acute nonspecific tenosynovitis, and post-traumatic osteoarthritis.
Intralesional administration of Flamicort injection 10 mg/ml is indicated for treatment of keloids, discoid lupus erythematosus, necrobiosis lipoidica diabeticorum, alopecia areata and localized hypertrophic, infiltrated, inflammatory lesions of: lichen planus, psoriatic plaques, granuloma annulare, and lichen simplex chronicus (neurodermatitis). Flamicort injection 10 mg/ml may be useful in cystic tumors of an aponeurosis or tendon (ganglia).